LOCUS       AIZ71989                 834 aa            linear   VRT 17-DEC-2014
DEFINITION  toll-like receptor 13, partial [Lissotriton montandoni].
ACCESSION   AIZ71989
VERSION     AIZ71989.1  GI:732553298
DBSOURCE    accession KP181489.1
KEYWORDS    .
SOURCE      Lissotriton montandoni (Carpathian newt)
  ORGANISM  Lissotriton montandoni
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
            Amphibia; Batrachia; Caudata; Salamandroidea; Salamandridae;
            Pleurodelinae; Lissotriton.
REFERENCE   1  (residues 1 to 834)
  AUTHORS   Babik,W., Dudek,K., Fijarczyk,A., Pabijan,M., Stuglik,M.,
            Szkotak,R. and Zielinski,P.
  TITLE     Constraint and adaptation in newt Toll-like receptor genes
  JOURNAL   Genome Biol Evol (2014) In press
   PUBMED   25480684
  REMARK    Publication Status: Available-Online prior to print
REFERENCE   2  (residues 1 to 834)
  AUTHORS   Babik,W., Dudek,K., Fijarczyk,A., Pabijan,M., Stuglik,M.,
            Szkotak,R. and Zielinski,P.
  TITLE     Direct Submission
  JOURNAL   Submitted (18-NOV-2014) Institute of Environmental Sciencs,
            Jagiellonian University, Gronostajowa 7, Krakow, Malopolskie
            30-387, Poland
COMMENT     ##Assembly-Data-START##
            Assembly Method       :: GATK Read-Backed Phasing v. 2.6; Phase v.
                                     2.1
            Sequencing Technology :: Illumina
            ##Assembly-Data-END##
FEATURES             Location/Qualifiers
     source          1..834
                     /organism="Lissotriton montandoni"
                     /isolate="TLR13_1998_B"
                     /db_xref="taxon:323754"
     Protein         <1..>834
                     /product="toll-like receptor 13"
     Region          61..376
                     /region_name="LRR_RI"
                     /note="leucine-rich repeats, ribonuclease inhibitor
                     (RI)-like subfamily; sd00033"
                     /db_xref="CDD:275380"
     Region          <77..167
                     /region_name="LRR_RI"
                     /note="Leucine-rich repeats (LRRs), ribonuclease inhibitor
                     (RI)-like subfamily. LRRs are 20-29 residue sequence
                     motifs present in many proteins that participate in
                     protein-protein interactions and have different functions
                     and cellular locations. LRRs correspond...; cl22710"
                     /db_xref="CDD:276664"
     Region          127..367
                     /region_name="LRR_RI"
                     /note="Leucine-rich repeats (LRRs), ribonuclease inhibitor
                     (RI)-like subfamily. LRRs are 20-29 residue sequence
                     motifs present in many proteins that participate in
                     protein-protein interactions and have different functions
                     and cellular locations. LRRs correspond...; cl22710"
                     /db_xref="CDD:276664"
     Site            order(133,136,138,141,143,157,160,162,165,183,186,188,189,
                     191,208,211,213,216,218,231,234,236,239,241,255,258,260,
                     263,265,278,281,284,286,307,310,312,315,317,331,334,336,
                     339,341,355,358,360,363,365)
                     /site_type="other"
                     /note="Leucine-rich repeats"
                     /db_xref="CDD:238064"
     Site            order(139..140,238,262,314,335,337,359)
                     /site_type="other"
                     /note="Substrate binding site [chemical binding]"
                     /db_xref="CDD:238064"
     Region          <322..509
                     /region_name="LRR_RI"
                     /note="Leucine-rich repeats (LRRs), ribonuclease inhibitor
                     (RI)-like subfamily. LRRs are 20-29 residue sequence
                     motifs present in many proteins that participate in
                     protein-protein interactions and have different functions
                     and cellular locations. LRRs correspond...; cl22710"
                     /db_xref="CDD:276664"
     Site            order(331,334,336,339,341,355,358,360,363,365,379,382,384,
                     387,389,403,406,408,411,427,430,432,435,437,451,454,456,
                     459,461,499,502,504,507,509)
                     /site_type="other"
                     /note="Leucine-rich repeats"
                     /db_xref="CDD:238064"
     Site            order(338,386,410,458,503,505)
                     /site_type="other"
                     /note="Substrate binding site [chemical binding]"
                     /db_xref="CDD:238064"
     Region          403..674
                     /region_name="LRR_RI"
                     /note="leucine-rich repeats, ribonuclease inhibitor
                     (RI)-like subfamily; sd00033"
                     /db_xref="CDD:275380"
     Region          <469..672
                     /region_name="LRR_RI"
                     /note="Leucine-rich repeats (LRRs), ribonuclease inhibitor
                     (RI)-like subfamily. LRRs are 20-29 residue sequence
                     motifs present in many proteins that participate in
                     protein-protein interactions and have different functions
                     and cellular locations. LRRs correspond...; cl22710"
                     /db_xref="CDD:276664"
     Site            order(475,478,480,483,485,499,502,504,507,512,523,526,528,
                     531,533,551,554,556,560,562,578,581,583,586,602,605,607,
                     610,629,632,634,640,642,653,656,658,661,663)
                     /site_type="other"
                     /note="Leucine-rich repeats"
                     /db_xref="CDD:238064"
     Site            order(482,530,559,609,633,638,657)
                     /site_type="other"
                     /note="Substrate binding site [chemical binding]"
                     /db_xref="CDD:238064"
     CDS             1..834
                     /gene="TLR13"
                     /coded_by="KP181489.1:<1..>2502"
ORIGIN      
        1 phpkitllls walsvaiqal lleaygyskc ifnntdaaga nctgygivnl taaidqlpnr
       61 trwldashns irmlevetfs hlsslqrlsl asnligeiqe gafrhlegln fldlsnnrir
      121 sldplyfael qslqvlqisy nniyslhtns lkpfvslqel dlsfnpisnf wlvaeaiqgl
      181 tklstlhltc igifdlkagq nltllpniqh lslaknniti ldftsyvmps lqyldvtrnn
      241 mtavnvssfh nvpnlvevvf dqnplnisqi ygfpltnlta lhwssmrpaf gedisaacql
      301 lqtlpnlnil diqhskirsr dlnfignctk lttinlstss lgklernafq sfgsletlyl
      361 nkckltqidp gafnnlkylh tlvvernrlk eleklvfrpl kklqnldlsk nfltlinpkg
      421 flglsglknl tlrnckiviv trdtftyvrk lvfldlssns ltlikhrtfe klnkleilll
      481 tgnrisaiqt lgfrglhslr ylslsrnhiy kldpdrfrfl rglsgldlsm nkltswnkfp
      541 npspfqelqs lkvldlsfqe ktgqfsipnq lfkglqslen lnlrgnpsmf fqnlsllpld
      601 nlteldlsdm ypsglfkfss dllrstrklk ylkldsnsfn dlpedafanl dsleilslrd
      661 ntltnisekl vgnlaaltyl dvymnpllcs cenvwfqnws nsnprvqvpl iqsfscfgkf
      721 edtisfteqd lsfcnndipr ilflctftit lltmiasilt vklrwvliyf ycmlrawcek
      781 kfhkevrahq fdafvsccte depwvmenll lnletlgprn yrlcfkprdf lpge
//

